As the SARS-CoV-2 virus continues to spread and evolve, notably SARS-CoV-2 variants such as Delta, Delta Plus, Alpha that increase the transmissibility and decrease the effectiveness of diagnostics, vaccines and therapeutics have caused surges in global COVID-19 cases.
To strengthen actions in epidemical control regarding the SARS-CoV-2 variants, WHO has classified them into 'Variants of Concern (VOC)' or 'Variants of Interest (VOI)' with a series of actions and measures.
Under such circumstances, a leading IVD raw materials and one-stop solution organization, Fapon Biotech, introduced the GRASPlex SARS-CoV-2 Full Length Genome Panel for SARS-CoV-2 known and emerging variant detection, virus source identification, mutation monitoring, study virus evolution, and others.
Product features & benefits
1. The sequencing output is more than 2M reads with Mapping Rate >99%, Ontarget Rate >95% and Uniformity Rate >95%
2. High uniformity with low copy number inputs
3. Excellent detection correlation between sample templates of different copy numbers
4. High-depth coverage of SARS-CoV-2 variant key mutation sites
For more information, download the product brochure>>